Showing results (1341-1350 of 1,459) with videos related to

Sort By:
Pageof 146
Applied Biosafety : Journal of the American Biological Safety Association|October 5, 2022
Biosafety Practices When Working with Bats: A Guide to Field Research ConsiderationsAlvaro Aguilar-Setién, Nidia Aréchiga-Ceballos, Gary A Balsamo, et al.
The Journal of Urology|June 10, 2020
A Multicenter Study of the Clinical Utility of Nontargeted Systematic Transperineal Prostate Biopsies in Patients Undergoing Pre-Biopsy Multiparametric Magnetic Resonance ImagingM J Connor, D Eldred-Evans, M van Son, et al.
Science Translational Medicine|February 21, 2012
T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizuresElizabeth Tringham, Kim L Powell, Stuart M Cain, et al.
Blood|August 11, 2011
Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaSebastian Schwind, Guido Marcucci, Jessica Kohlschmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid LeukemiaTimothy S Pardee, Rebecca G Anderson, Kristin M Pladna, et al.
The Journal of Clinical Endocrinology and Metabolism|May 6, 2004
Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosteroneMichelle Gaasenbeek, Brenda L Powell, Ulla Sovio, et al.
Journal of Medicinal Chemistry|March 31, 2006
1,4-Benzodiazepines as inhibitors of respiratory syncytial virusMalcolm C Carter, Dagmar G Alber, Robert C Baxter, et al.
Blood|April 2, 2008
High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) studyChristian Langer, Michael D Radmacher, Amy S Ruppert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2008
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B StudyGuido Marcucci, Kati Maharry, Michael D Radmacher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2021
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid TumorsMichael L Maitland, Jasgit C Sachdev, Manish R Sharma, et al.
Pageof 146